Unexpected results from a new study revealed that men who smoke had less risk of undergoing total hip replacement surgery than those who never smoked, medical experts say. The implant devices used in hip replacement operation such as Stryker is going to remedy the surgeries performed as complaints arise from its users.
In the current study, George Mnatzaganian, a PhD student from the University of Adelaide in Australia, and colleagues examined the associations of smoking, body mass index, and physical activity as they relate to risk of joint replacement surgery in men. Clinical data for the 11,388 male study participants, who were part of the Health in Men Study, were integrated with hospital morbidity data and mortality records. During the initial health screening (1996-1999), subjects were surveyed regarding smoking history and physical activity.
Study showed that being overweight independently increased total joint replacement risk, while smoking lowered the risk, which was most apparent after 23 years of smoking exposure. In fact, men who smoked 48 years or more were up to 51 percent unlikely to undergo total joint replacements than those who never smoked.
“Further investigation is needed to determine how smoking impacts the development of osteoarthritis,” Mnatzaganian said.
Stryker Hip Replacement Lawsuit
medscape.org/viewarticle/746262 Read More
Recently developed, all-metal hip implants have raised many concerns because of the many problems of patients who have had the device implanted in them, news reports say. Health care costs have risen due to the difficulties in the economy. However, there are several men and women who are filing DePuy Pinnacle hip implant cases due to faulty hip devices.
Patients who have had hip replacement surgery but who ended up having a faulty hip implant may need to undergo another surgery to correct it. This may lead to higher expenditures on health care, the New York Times reported, showing that medical and legal industry experts perceived that there might even be billions of dollars that will be spent in the coming years.
There are more or less 125,000 patients who experienced dialysis treatment with the use of NaturaLyte or GranuFlo. Both products are manufactured by Fresenius and are used at several dialysis centers all over the United States. Because of the serious side effects the drugs may cause, the Food and Drug Administration issued a Class 1 recall for both medications. A Class 1 recall is categorized as the highest level of recall and is only used for drugs or medical products that cause major health problems and death. The main reason for the recall was due to the dialysates elevating bicarbonate levels in the patient’s body to the point where a condition called metabolic alkalosis can happen.
GranuFlo and NaturaLyte concentrates are used to treat chronic and acute renal failure during hemodialysis, wherein a machine filters salts, wastes, and fluids from the blood. This is done when the kidneys can no longer perform the essential bodily function.
Patients who suffer the negative effects are beginning to file individual GranuFlo lawsuit. Those who have used either NaturaLyte or GranuFlo during dialysis are prone to experience cardiac problems, like low blood pressure, irregular heart rate and heart attack. Other cardiac events include excessive carbon dioxide in the blood, low blood pressure and low potassium and oxygen in the blood. Patients also have increased chances of having a stroke.
The Food and Drug Administration (FDA) received reports that Fresenius knew about the possible side effects but withheld the information. In fact, an internal memo has been sent to doctors at Fresenius clinics noting that 941 Fresenius patients have suffered heart attacks after using GranuFlo or NaturaLyte. Fresenius failed to inform customer hospitals and clinics of the fatal risk linked to their dialysis products. The FDA is investigating whether Fresenius has violated federal regulations by only informing clinics belonging to their group.
If one is familiar about the vaginal mesh lawsuit issue, one has a clear idea about the issues tied with pelvic organ prolapse (POP). In line with this, a study was made around 182 patients who are affected by the medical condition called POP. These patients have had to go through a traditional prolapsed surgery as part of the experimental study.
This experiment was done from January 20, 2000 to March 24, 2009 and results of the study have just been released. It was found out that anatomic support were satisfactory after traditional prolapsed surgery which means this may be hope springing good for individuals who have been severely affected by POP.
Vaginal Mesh Complications VideoRead More
Almost everyone are familiar with transvaginal mesh and lawsuits, especially on how it has affected one of the most problematic medical condition called the stress urinary incontinence (SUI). People who aredistressed with this most likely had been into many different embarrassing situations as it can be triggered with very mundane things like laughing or sneezing. Now, isn’t it quite a blow when the problem about tansvaginal mesh erupted? Where can SUI affected seek solace from now on?
Kenneth Peters, a urologist, has found out that certain muscles may help in the treatment of SUI but patients have to go under a leg biopsy first. Cells in this muscle will be isolated and injected on the patient to help regenerate muscles which results to bladder control. Final results about this procedure are still to be determined but on-hand results seem to be promising. Hopefully, within next year, final results are already available.